Ironwood Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Ironwood Pharmaceuticals Inc cash flow-to-debt ratio. Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow-to-Debt Ratio of 0.13x as of June 2026, meaning its operating cash flow of $58.28 Million could theoretically repay 0% of its total liabilities ($446.97 Million) in one year. Check Ironwood Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ironwood Pharmaceuticals Inc (2007–2025)
Cash flow-to-debt ratio of Ironwood Pharmaceuticals Inc from 2007 to 2025. Historical debt coverage capacity for Ironwood Pharmaceuticals Inc across 19 annual periods. Check Ironwood Pharmaceuticals Inc (IRWD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ironwood Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2007–2025)
Ironwood Pharmaceuticals Inc cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Ironwood Pharmaceuticals Inc. For the full cash flow conversion analysis, see Ironwood Pharmaceuticals Inc (IRWD) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $127.04 Million | $658.74 Million | ▲ +21.5% |
| 2024 | 0.16x | $103.55 Million | $652.24 Million | ▼ -29.3% |
| 2023 | 0.22x | $183.43 Million | $817.37 Million | ▼ -63.3% |
| 2022 | 0.61x | $273.76 Million | $448.14 Million | ▲ +21.5% |
| 2021 | 0.50x | $261.89 Million | $521.02 Million | ▲ +47.8% |
| 2020 | 0.34x | $168.84 Million | $496.60 Million | ▲ +1472.3% |
| 2019 | 0.02x | $10.72 Million | $496.00 Million | ▲ +116.1% |
| 2018 | -0.13x | $-70.88 Million | $528.42 Million | ▲ +19.7% |
| 2017 | -0.17x | $-99.56 Million | $595.83 Million | ▼ -322.5% |
| 2016 | -0.04x | $-25.43 Million | $643.11 Million | ▲ +80.6% |
| 2015 | -0.20x | $-106.93 Million | $524.00 Million | ▲ +67.9% |
| 2014 | -0.64x | $-155.57 Million | $244.96 Million | ▲ +44.1% |
| 2013 | -1.14x | $-273.36 Million | $240.74 Million | ▼ -40.0% |
| 2012 | -0.81x | $-69.63 Million | $85.86 Million | ▼ -6.9% |
| 2011 | -0.76x | $-75.24 Million | $99.12 Million | ▼ -58.5% |
| 2010 | -0.48x | $-67.90 Million | $141.81 Million | ▼ -5418.3% |
| 2009 | -0.01x | $-4.00 Million | $460.79 Million | ▲ +88.6% |
| 2008 | -0.08x | $-28.20 Million | $371.13 Million | ▼ -253.2% |
| 2007 | -0.02x | $-6.76 Million | $314.28 Million | — |